Vermillion: You Can’t Cure the Disease Until You Can Diagnose It
With Gail Page, CEO. Austin’s burgeoning biotech scene can be typified by its ability to quickly and successfully bring bioscience from university labs to the market. Vermillion is working with institutions like Johns Hopkins, M.D. Anderson, and Stanford to discover bio markers for a variety of unmet clinical needs. They have... [read more]

Vermillion: You Can’t Cure the Disease Until You Can Diagnose It
With Gail Page, CEO. Austin’s burgeoning biotech scene can be typified by its ability to quickly and successfully bring bioscience from university labs to the market. Vermillion is working with institutions like Johns Hopkins, M.D. Anderson, and Stanford to discover bio markers for a variety of unmet clinical needs. They have created or are creating novel diagnostics for such diseases as Ovarian Cancer and Peripheral Arterial Disease.